Is SCHD a Good ETF to Buy?
With around $65.7 billion in net assets, Schwab’s US Dividend…
Sell
24
VNDA Quote, Financials, Valuation and Earnings
Last price:
$4.86
Seasonality move
:
-4.37%
Day range:
$4.77 - $4.89
52-week range:
$3.46 - $6.75
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
1.46x
P/B ratio:
0.52x
Volume:
510.4K
Avg. volume:
616.7K
1-year change:
14.32%
Market cap:
$279.3M
Revenue:
$192.6M
EPS (TTM):
-$0.28
VNDA Analysts' Consensus Rating
The 2 analysts providing 12-month price projections for Vanda Pharmaceuticals shares anticipate an average target of $12.17, ranging from a low estimate of $5.50 to a high estimate of $18.00. This average target implies a growth of 154% compared to the current stock price of $4.79.
Consensus Price Target
$12.17
Highest Price Target
$18.00
Lowest Price Target
$5.50
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Analyst Ratings
| 6M Ago | 1M Ago | Current | |
|---|---|---|---|
| Buy | 1 | 1 | 1 |
| Hold | 0 | 1 | 1 |
| Sell | 0 | 0 | 0 |
| Consensus | Buy | Leans Bullish | Leans Bullish |
VNDA Recommendation Trends
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is NAIL a Good ETF to Buy?
If you’re thinking about buying the NAIL ETF, this article…
3 High Dividend Dow Jones Stocks
Thanks to surging stock prices over the past two years,…
Stock Ideas
Sell
42
Is AAPL Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 40x
Buy
59
Is NVDA Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 125x
Sell
46
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 36x
Alerts
Sell
50
NARI alert for Jan 7
Inari Medical [NARI] is up 22.25% over the past day.
Buy
70
PDEX alert for Jan 7
Pro-Dex [PDEX] is down 10.89% over the past day.
Buy
52
ALCO alert for Jan 7
Alico [ALCO] is down 3.89% over the past day.
